Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iRhythm Holdings (IRTC) Current Deferred Revenue (2016 - 2025)

iRhythm Holdings (IRTC) has disclosed Current Deferred Revenue for 11 consecutive years, with $4.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue rose 44.83% to $4.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.2 million, a 44.83% increase, with the full-year FY2025 number at $4.2 million, up 44.83% from a year prior.
  • Current Deferred Revenue was $4.2 million for Q4 2025 at iRhythm Holdings, down from $4.2 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $4.2 million in Q3 2025 to a low of $1.4 million in Q1 2021.
  • A 5-year average of $3.1 million and a median of $3.1 million in 2022 define the central range for Current Deferred Revenue.
  • Peak YoY movement for Current Deferred Revenue: surged 227.85% in 2021, then decreased 14.86% in 2024.
  • iRhythm Holdings' Current Deferred Revenue stood at $3.0 million in 2021, then increased by 0.07% to $3.1 million in 2022, then rose by 8.16% to $3.3 million in 2023, then dropped by 12.12% to $2.9 million in 2024, then soared by 44.83% to $4.2 million in 2025.
  • Per Business Quant, the three most recent readings for IRTC's Current Deferred Revenue are $4.2 million (Q4 2025), $4.2 million (Q3 2025), and $3.5 million (Q2 2025).